Legal status in the United States
Is Sermorelin legal?
Read at FDA, DEA and WADAPublished by PepVault
Sermorelin was FDA-approved as Geref in 1990, and Drugs@FDA now lists it as discontinued, is not a federally controlled substance, and is banned in sport (WADA names it under S2.2.4), as of November 18, 2026.
Sermorelin at a glance
| Check | Status, read Nov 18, 2026 |
|---|---|
| FDA approval | Approved 1990; discontinued (Drugs@FDA) |
| Compounding | Component of an approved drug (503A condition) |
| DEA schedule | Not controlled |
| Sport (WADA) | Banned, named (S2.2.4) |
FDA approval
Sermorelin was FDA-approved as Geref, in 1990 and 1997, and is no longer sold: its maker discontinued both products in 2008, and FDA determined in 2013 that they were not withdrawn for reasons of safety or effectiveness.
Geref (injection (0.05 mg ampule))
Approved for a test of how well the pituitary gland releases growth hormone. NDA 019863, first approved December 28, 1990; discontinued (2008).
- Drugs@FDA: Geref, application 019863, U.S. Food and Drug Administration. Read .
- Determination That GEREF (Sermorelin Acetate) Injection … Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness (March 4, 2013), Federal Register. Read .
Geref (injection (vials))
Approved for growth hormone deficiency in children with growth failure. NDA 020443, first approved September 26, 1997; discontinued (2008).
- Drugs@FDA: Geref, application 020443, U.S. Food and Drug Administration. Read .
- Determination That GEREF (Sermorelin Acetate) Injection … Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness (March 4, 2013), Federal Register. Read .
The source: “were not withdrawn for reasons of safety or effectiveness”
- Drugs@FDA: Geref, application 019863, U.S. Food and Drug Administration. Read .
- Determination That GEREF (Sermorelin Acetate) Injection … Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness (March 4, 2013), Federal Register. Read .

Compounding
Sermorelin is the active ingredient of an FDA-approved drug, Geref, discontinued by its maker in 2008; FDA determined in 2013 that Geref was not withdrawn for reasons of safety or effectiveness. FDA’s page on bulk drug substances gives three conditions under section 503A for a substance a pharmacy compounds from, and one of them is being a component of an FDA-approved drug product; the 503A and 503B bulks lists don’t name sermorelin.
The source: “Are components of FDA-approved drug products if an applicable USP or NF monograph does not exist”
- Bulk Drug Substances Used in Compounding (content current as of March 26, 2026), U.S. Food and Drug Administration. Read .
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act (updated May 14, 2026), U.S. Food and Drug Administration. Read .
- 503B Bulk Drug Substances List (content current as of May 16, 2024), U.S. Food and Drug Administration. Read .
- Determination That GEREF (Sermorelin Acetate) Injection … Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness (March 4, 2013), Federal Register. Read .
DEA schedule
It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.
- 21 CFR Part 1308, Schedules of Controlled Substances (eCFR, up to date as of November 16, 2026), Electronic Code of Federal Regulations. Read .
- Controlled Substances, Alphabetical Order (dated November 17, 2026), Drug Enforcement Administration, Diversion Control Division. Read .
Sport (WADA)
WADA bans sermorelin at all times, in and out of competition: the 2026 list names it under S2.2.4, growth hormone releasing factors.
The source: “growth hormone-releasing hormone (GHRH) and its analogues (e.g. CJC-1293, CJC-1295, sermorelin and tesamorelin)”
- World Anti-Doping Code International Standard, Prohibited List 2026 (in effect from January 1, 2026), World Anti-Doping Agency. Read .
What this means and doesn’t
This page reports what the agencies’ own pages said about Sermorelin in the United States when we read them on November 18, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.
It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.
Questions
Is Sermorelin FDA approved?
Sermorelin was FDA-approved as Geref, in 1990 and 1997, and is no longer sold: its maker discontinued both products in 2008, and FDA determined in 2013 that they were not withdrawn for reasons of safety or effectiveness.
Is Sermorelin a controlled substance?
It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.
Is Sermorelin banned in sport?
WADA bans sermorelin at all times, in and out of competition: the 2026 list names it under S2.2.4, growth hormone releasing factors.
What does FDA say about compounding Sermorelin?
Sermorelin is the active ingredient of an FDA-approved drug, Geref, discontinued by its maker in 2008; FDA determined in 2013 that Geref was not withdrawn for reasons of safety or effectiveness. FDA’s page on bulk drug substances gives three conditions under section 503A for a substance a pharmacy compounds from, and one of them is being a component of an FDA-approved drug product; the 503A and 503B bulks lists don’t name sermorelin.